The Impact of COVID-19 Infection on the Development of Stroke, Pulmonary Embolism, and Myocardial Infarction: A Retrospective Study

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2025 Feb 19

PMID 39968441

Authors

Oya Guven

Gokhan Karakurt

Abdulrahman Naser

Hakan Selcuk

Dilek V Keles

Emre Gedik

Mert Avsever

Fatih Furkan Kose

Affiliations

Soon will be listed here.

Abstract

Introduction: This study compares the period during which thromboembolic disease develops after contact with the virus before, during, and after the pandemic.

Methods: In this study, the medical records of patients with a preliminary diagnosis of myocardial infarction (MI), pulmonary embolism (PE), and ischemic stroke who presented to the Emergency Department before, during, and after the pandemic (when vaccination rates increased) were retrospectively examined. Data on whether these patients had COVID-19 or were vaccinated, the time interval between infection/vaccination and the onset of these conditions, and the prognosis were analyzed.

Results: In the MI group, patients developed embolism the longest after infection and the shortest after vaccination. Among MI patients, the rate of those who received the BioNTech vaccine during the normalization period was higher than that of those who received Sinovac (p = 0.005). In stroke patients, during the pandemic, the time to post-vaccine embolism was shorter (p < 0.001). Additionally, infection and vaccination increased the mortality rate in stroke and PE patients (p < 0.001).

Conclusion: This study demonstrates that thromboembolic events can occur at varying rates and durations after exposure to the virus. While the causes of thrombosis are multifactorial, contact with the virus may act as a triggering factor, even if COVID-19 does not have a direct effect.

References

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Pessoa-Amorim G, Camm C, Gajendragadkar P, De Maria G, Arsac C, Laroche C . Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes. 2020; 6(3):210-216. PMC: 7543872. DOI: 10.1093/ehjqcco/qcaa046. View

Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

Konstantinides S, Meyer G, Becattini C, Bueno H, Geersing G, Harjola V . 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2019; 41(4):543-603. DOI: 10.1093/eurheartj/ehz405. View

Tang N, Li D, Wang X, Sun Z . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4):844-847. PMC: 7166509. DOI: 10.1111/jth.14768. View

Driggin E, Madhavan M, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G . Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020; 75(18):2352-2371. PMC: 7198856. DOI: 10.1016/j.jacc.2020.03.031. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

Libert C, Dejager L, Pinheiro I . The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol. 2010; 10(8):594-604. DOI: 10.1038/nri2815. View

Madjid M, Safavi-Naeini P, Solomon S, Vardeny O . Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020; 5(7):831-840. DOI: 10.1001/jamacardio.2020.1286. View

10.

White R, Zhou H, Murin S, Harvey D . Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost. 2005; 93(2):298-305. DOI: 10.1160/TH04-08-0506. View

11.

Merkler A, Parikh N, Mir S, Gupta A, Kamel H, Lin E . Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurol. 2020; . PMC: 7333175. DOI: 10.1001/jamaneurol.2020.2730. View

12.

Ageno W, Antonucci E, Poli D, Bucherini E, Chistolini A, Fregoni V . Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes. Res Pract Thromb Haemost. 2023; 7(4):100167. PMC: 10131739. DOI: 10.1016/j.rpth.2023.100167. View

13.

Vahidy F, Pan A, Ahnstedt H, Munshi Y, Choi H, Tiruneh Y . Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area. PLoS One. 2021; 16(1):e0245556. PMC: 7806140. DOI: 10.1371/journal.pone.0245556. View

14.

Jabagi M, Botton J, Bertrand M, Weill A, Farrington P, Zureik M . Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA. 2021; 327(1):80-82. PMC: 8609457. DOI: 10.1001/jama.2021.21699. View

15.

Taylor B, Khandelwal P, Rallo M, Patel P, Smith L, Sun H . Outcomes and Spectrum of Major Neurovascular Events Among COVID-19 Patients: A 3-Center Experience. Neurosurg Open. 2021; 1(3):okaa008. PMC: 7454798. DOI: 10.1093/neuopn/okaa008. View

16.

Oger E . Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000; 83(5):657-60. View

17.

Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X . High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020; 46(6):1089-1098. PMC: 7197634. DOI: 10.1007/s00134-020-06062-x. View

18.

Aksu K, Donmez A, Keser G . Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. 2012; 18(11):1478-93. DOI: 10.2174/138161212799504731. View

19.

Nannoni S, de Groot R, Bell S, Markus H . Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2020; 16(2):137-149. PMC: 7859578. DOI: 10.1177/1747493020972922. View

20.

Kurt Sr B, Guven O, Selcuk H . The Effect of the COVID-19 Pandemic on Emergency Department (ED) Admissions in the Only Hospital of City Center ED. Cureus. 2023; 15(9):e44527. PMC: 10544729. DOI: 10.7759/cureus.44527. View